- Home
- / Zhaoke Ophthalmology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Zhaoke Ophthalmology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.4
2024-10-29
Market Capitalization
$759.1 M
2024-10-29
Revenue
¥32 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 18.8M | 69.3M | 32.0M | ||||
| Cost of goods sold | 4.5M | (36.0M) | 15.9M | ||||
| Gross profit | 62.0K | 65.9M | 16.1M | 7.6M | 18.9M | 117.4M | 16.8M |
| Gross profit margin, % | 100.8% | 169.4% | 52.5% | ||||
| Operating expense total | 83.1M | 98.5M | 373.0M | 377.4M | 420.6M | 338.0M | 239.5M |
| Depreciation and amortization | 16.6M | 19.9M | 25.8M | 35.1M | 48.7M | 53.6M | 52.3M |
| EBITDA | (83.1M) | (32.6M) | (356.9M) | (369.8M) | (401.7M) | (220.5M) | (222.7M) |
| EBITDA margin, % | -2142.7% | -318.1% | -696.5% | ||||
| EBIT | (99.7M) | (52.4M) | (382.8M) | (404.9M) | (450.3M) | (273.5M) | (272.7M) |
| EBIT margin, % | -2401.7% | -394.6% | -852.9% | ||||
| Interest income | 2.9M | 2.6M | 5.0M | 30.4M | 77.4M | 75.2M | 44.4M |
| Interest expense | 26.4M | 671.6M | 1.8B | 3.1M | 7.9M | 9.5M | 9.1M |
| Pre tax profit | (122.1M) | (727.0M) | (2.1B) | (407.3M) | (384.5M) | (237.5M) | (209.0M) |
| Income tax expense | 550.0K | ||||||
| Net Income | (122.1M) | (727.0M) | (2.1B) | (407.3M) | (385.0M) | (237.5M) | (209.0M) |